H.Amdt.719 - An amendment numbered 9 printed in Part B of House Report 116-334 to require drug companies to disclose truthful and non-misleading pricing information about prescription drugs and biological products when they advertise these products directly to consumers.
About This Bill
Passed
Latest Action · December 12, 2019
On agreeing to the Finkenauer amendment (A009) Agreed to by voice vote.